Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability

被引:69
作者
Hasanovic, Amra [1 ]
Zehl, Martin [2 ]
Reznicek, Gottfried [2 ]
Valenta, Claudia
机构
[1] Univ Vienna, Dept Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria
关键词
chitosan-tripolyphosphate nanoparticles; skin diffusion; aciclovir; differential scanning calorimetry; LC/MS; ABSORPTION; MECHANISM; POLYMERS;
D O I
10.1211/jpp/61.12.0004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives The aim of the present study was to create a skin delivery system based on chitosan-tripolyphosphate nanoparticles for aciclovir with enhanced chemical stability. Methods Nanoparticles were formed spontaneously using ionotropic gelation with tripolyphosphate. Two different sizes of aciclovir-loaded nanoparticles were characterised in terms of zeta potential, particle size and polydispersity index. Key findings Standard diffusion experiments using Franz-type diffusion cells showed reasonable skin permeability that depended on particle size and chitosan content. The larger the nanoparticle, having a higher chitosan content, the better the aciclovir permeation through porcine skin. Differential scanning calorimetry studies showed a remarkable decrease in the typical transition temperature, indicating an interaction between skin lipid bilayer and the nanoparticles. Moreover, the chemical stability of aciclovir was significantly increased by the nanoparticle system. After the observation period of 5 weeks, aciclovir incorporated into nanoparticles had undergone photo-oxidation to a significantly lower extent than pure aqueous solution. This degradation product of aciclovir was analysed using LC/MS, and its identity established. Conclusions These studies demonstrate that incorporation of aciclovir into chitosan-tripolyphosphate nanoparticles significantly improves its chemical stability. Moreover, skin diffusion studies in vitro showed improved permeation of aciclovir from the nanoparticle system, especially from nanoparticles with higher chitosan content.
引用
收藏
页码:1609 / 1616
页数:8
相关论文
共 21 条
[1]  
BHUMKAR DR, 2006, PHARM SCI TECHNOL TO, V7, P1
[2]   Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles [J].
Bodnar, Magdolna ;
Hartmann, John F. ;
Borbely, Janos .
BIOMACROMOLECULES, 2006, 7 (11) :3030-3036
[3]   Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery [J].
Cuna, M. ;
Alonso-Sande, M. ;
Remunan-Lopez, G. ;
Pivel, J. P. ;
Alonso-Lebrero, J. L. ;
Alonso, M. J. .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2006, 6 (9-10) :2887-2895
[4]   Chitosan nanoparticles as a potential drug delivery system for the ocular surface:: Toxicity, uptake mechanism and in vivo tolerance [J].
de Salamanca, AE ;
Diebold, Y ;
Calonge, M ;
García-Vazquez, C ;
Callejo, S ;
Vila, A ;
Alonso, MJ .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (04) :1416-1425
[5]   Chitosan as tear substitute: A wetting agent endowed with antimicrobial efficacy [J].
Felt, O ;
Carrel, A ;
Baehni, P ;
Buri, P ;
Gurny, R .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2000, 16 (03) :261-270
[6]   Enhancement of nasal absorption of insulin using chitosan nanoparticles [J].
Fernández-Urrusuno, R ;
Calvo, P ;
Remuñán-López, C ;
Vila-Jato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1576-1581
[7]  
GOLDEN MG, 1986, BIOCHEMISTRY-US, V26, P2382
[8]  
HIRVONEN J, 1994, EUR J PHARM BIOPHARM, V40, P81
[9]   Effect of selected fluorinated drugs in a "ringing" gel on rheological behaviour and skin permeation [J].
Hoeller, Sonia ;
Valenta, Claudia .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (01) :120-126
[10]  
KAHLIG H, 2009, DRUG DEV IND PHARM, V1, P1